Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-16

Clinical Trial Update: Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP) [Phase 2]

View source ↗

Summary

A Phase 2 trial called CLAMP evaluating the effect of DMMET-01 on insulin sensitivity in drug-naive type 2 diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DMMET-01

Snippet

Sponsor: Laboratorios Silanes S.A. de C.V. | Conditions: Diabetes Type 2 | Phase 2 | Status: COMPLETED